To evaluate the role of gabapentin for the treatment of neuropathic pain.
DATA SOURCES:
Clinical literature was identified through MEDLINE (from 1990 to October 1999). Key search terms were gabapentin and pain.
DATA SYNTHESIS:
Neuropathic pain can be a problematic, chronic syndrome that is frequently refractory to current drug treatments. Gabapentin is a newer generation antiepileptic drug that is commonly used in treatment of neuropathic pain. An evaluation of clinical trials using gabapentin to treat neuropathic pain was performed.
CONCLUSIONS:
Gabapentin appears to be effective in treating various neuropathic pain disorders. Gabapentin may have advantages over current therapies, such as a favorable safety profile and lack of drug interactions; however, cost issues and limited experience may limit the use of gabapentin as a first-line option.
RosenbergJMHarrellCRisticHWernerRAde RosayroAM. The effect of gabapentin on neuropathic pain. Clin J Pain1997;13:251–5.
5.
NessTJCrimaldiJCMcDanalJT. Case report on gabapentin (letter). Reg Anesth1998;23:110–1.
6.
BackonjaMBeydounAEdwardsKRSchwartzSLFonsecaVHesMGabapentin monotherapy for the symptomatic treatment of painful neuropathy. A multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. JAMA1998;280:1831–6.
7.
RowbothamMHardenNStaceyBBernsteinPMagnus-MillerL. Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial. JAMA1998;280:1837–42.
8.
RosnerHRubinLKestenbaumA. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain1996;12:56–8.
9.
SegalAZRordorfG. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology1996;46:1175–6.
10.
SistTCFiladoraVAMinerMLemaM. Experience with gabapentin for neuropathic pain in the head and neck. Report of ten cases. Reg Anesth1997;22:473–8.
11.
MerrenMD. Gabapentin for the treatment of pain and tremor. A large case series. South Med J1998;91:739–44.
12.
SistTFiladoraVMinerMLemaM. Gabapentin for idiopathic trigeminal neuralgia. Report of two cases (letter). Neurology1997;48:1467.
13.
KhanOA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology1998;51:611–4.
14.
SolaroCLunardiGLCapelloEIngleseMUccelliM MessmerUccelliAAn open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology1998;51:609–11.
15.
TaylorCPGeeNSSuTZKocsisJDWeltyDFBrownJPA summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res1998;29:233–49.
16.
PetroffOARothmanDLBeharKLLamoureuxDMattsonRH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol1996;39:95–9.
17.
GotzEFeuersteinTJMeyerDK. Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Drug Res1993;43:636–8.
18.
GoldlustASuTZWeltyDFTaylorCPOxenderDL. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res1995;22:1–11.
19.
GeeNSBrownJPDissanayakeVUOffordJThurlowRWoodruffGN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the α2δ subunit of a calcium channel. J Biol Chem1996;271:5768–76.
20.
BoydRATurckDAbelRBSedmanAJBockbraderHN. Effects of age and gender on single-dose pharmacokinetics of gabapentin. Epilepsia1999;40:474–9.
21.
SchachterSCCarrazanaEJ. Treatment of facial pain with gabapentin (letter). J Epilepsy1997;10:148–9.
22.
SchachterSCSauterMK. Treatment of central pain with gabapentin (letter). J Epilepsy1996;9:223–4.
23.
MellickGAMellickLB. Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil1997;78:98–105.
24.
ZappJJ. Postpoliomyelitis pain treated with gabapentin (letter). Am Fam Physician1996;53:2442–3.
25.
McGrawTKosekP. Erythromelalgia pain managed with gabapentin. Anesthesiology1997;86:988–90.
26.
SamkoffLMDarasMTuchmanAJKoppelBS. Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology1997;49:304–5.
27.
McGrawTStaceyBR. Gabapentin for treatment of neuropathic pain in a 12-year-old girl. Clin J Pain1998;14:354–6.
28.
NessTJSan PedroECRichardsJSKezarLLiuHGMountzJM. A case of spinal cord injury—related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin. Pain1998;78:139–43.
29.
KostRGStrausSE. Postherpetic neuralgia. Pathogenesis, treatment, and prevention. N Engl J Med1996;335:32–42.
30.
FedeleDGiuglianoD. Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management. Drugs1997;54:414–21.
31.
GorsonKCSchottCHermanRRopperAHRandWM. Gabapentin in the treatment of painful diabetic neuropathy. A placebo controlled, double blind, crossover trial (letter). J Neurol Neurosurg Psychiatry1998;62:251–2.
32.
ArnerSLindblomUMeyersonBAMolanderC. Prolonged relief of neuralgia after regional anesthetic blocks. A call for further experimental and systematic clinical studies. Pain1990;43:287–97.
33.
MorelloCMLeckbandSGStonerCPMoorhouseDFSahagianGA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med1999;159:1931–7.
34.
MaxMBLynchSAMuirJShoafSESmollerBDubnerR. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med1992;326:1250–6.
35.
ChadwickDWAnhutHGreinerMJAlexanderJMurrayGHGarofaloEAA double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology1998;51:1282–8.
36.
McQuayHCarrollDJadadARWiffenPMooreA. Anticonvulsant drugs for management of pain. A systematic review. BMJ1995;311: 1047–52.
37.
1999 Drug topics red book. Montvale, NJ: Medical Economics, 1999.
